Explore more publications!

Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

Press releases published on January 27, 2026

Addiction Treatment Center Warns About Staggering Untreated Addiction Rates in Oklahoma
Life Extension Launches New Bio-Luteolin™ Supplement  for Healthy Aging Benefits
First Steroid Cycle for Bodybuilders – CrazyBulk | Steroids for Beginners Bulking and Cutting: Safest Steroids for Bodybuilding
Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer
PreatLoc™ by Preat® is Now Available
Canix Acquires Major Competitor Trym To Create Industry-Leading ERP Management For Cannabis Industry
Global Pharmaceutical Manufacturing Software Market to Reach USD 5.52 Billion by 2030 | MarketsandMarkets™
Halo Pharma to become a stand-alone Drug Product Contract Development and Manufacturing Organization (CDMO)
INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives
Evosep Launches IQ/OQ Protocols for the Evosep Eno System at WCBP 2026
Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation
Organizations Join Forces to Map How Human Muscle Regenerates
Bicycle Health Appoints Rick Dean as Chief Executive Officer to Lead Next Phase of Growth
Nextech Pioneers New Era in Clinical Documentation with Launch of AI-Powered Cora Scribe
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
Imprivata Pledges Support for CMS “Kill the Clipboard” Initiative to Simplify and Secure Patient Access to Medical Records
Global Clinical Mass Spectrometry Market to Reach USD 3.31 Billion by 2031 | MarketsandMarkets™
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions